Cyclacel (CYCC) Pressured as Short Interest Nearly Doubles in December
Tweet
Share
E-mailGet Alerts CYCC Hot Sheet
Join SI Premium – FREE
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) shares are in negative territory today amid new market data showing a notable increase in short interest.
Since the last update on November 30, short interest on Cyclacel rose 92.4 percent, or 698,476 shares, to a total of 1,424,567 shares as of December 14th.
Short positions are about 18.2 percent of market float with days to cover at 2.
Shares are down about 5 percent Thursday.
Since the last update on November 30, short interest on Cyclacel rose 92.4 percent, or 698,476 shares, to a total of 1,424,567 shares as of December 14th.
Short positions are about 18.2 percent of market float with days to cover at 2.
Shares are down about 5 percent Thursday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UGI Corp. (UGI) halted on volatility, up 6%
- Uber sells part of its Aurora stake in block trade - Bloomberg
- Amazon: to grow Louisiana data center investment from $12 billion to $18 billion with a third data center campus
Create E-mail Alert Related Categories
Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
